D Kuruppu
Overview
Explore the profile of D Kuruppu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su L, Jin Y, Unverzagt F, Liang C, Cheng Y, Hake A, et al.
J Nutr Health Aging
. 2016 Dec;
20(10):983-988.
PMID: 27925137
Objectives: Results from previous studies have been inconsistent on the association between selenium and hypertension, and very few studies on this subject have focused on the elderly population. The purpose...
2.
Kuruppu D, Tanabe K
Cancer Gene Ther
. 2015 Sep;
22(10):506-8.
PMID: 26384139
Meningeal metastasis is a fatal complication of breast cancer that affects 5-8% of patients. When cancer cells seed in the meninges, their subsequent growth results in severe neurological complications involving...
3.
Kulu Y, Dorfman J, Kuruppu D, Fuchs B, Goodwin J, Fujii T, et al.
Cancer Gene Ther
. 2008 Nov;
16(4):291-7.
PMID: 18989355
hrR3 is an oncolytic herpes simplex virus 1 (HSV-1) mutant that replicates preferentially in tumors compared with normal tissues. Portal venous administration of hrR3 in mice bearing diffuse colorectal carcinoma...
4.
Sanchez-Pernaute R, Wang J, Kuruppu D, Cao L, Tueckmantel W, Kozikowski A, et al.
Neuroimage
. 2008 May;
42(1):248-51.
PMID: 18501638
The interplay between dopamine and glutamate in the basal ganglia regulates critical aspects of motor learning and behavior. Metabotropic glutamate receptors (mGluR) are increasingly regarded as key modulators of neuroadaptation...
5.
Kuruppu D, Christophi C, Bertram J, OBrien P
J Gastroenterol Hepatol
. 1998 Jun;
13(5):521-7.
PMID: 9641652
Liver metastases account for over 70% of deaths resulting from colorectal carcinoma, with survival rates varying between 6-18 months. At present, surgical resection offers the only hope for a cure,...
6.
Kuruppu D, Christophi C, OBrien P
HPB Surg
. 1997 Jan;
10(3):149-57; discussion 158.
PMID: 9174859
Development of effective treatment for hepatic metastases can be initiated by a better understanding of tumour vasculature and blood supply. This study was designed to characterise the microvascular architecture of...
7.
Kuruppu D, Christophi C, Bertram J, OBrien P
J Gastroenterol Hepatol
. 1996 Jan;
11(1):26-32.
PMID: 8672738
The experimental study of possible therapies for control of the growth of liver metastases requires the availability of a model which is technically feasible and appears to exhibit growth characteristics...